Phase II results presented for the new oral combination of faldaprevir, deleobuvir and PPI-668 Dec. 31, 2013
NAMPT as a new genetic marker associated with susceptibility, severity and outcome of CAD Dec. 31, 2013
Chinese herbal medicine demonstrates safety and efficacy in first U.S. trial in liver fibrosis Dec. 30, 2013
RSS